Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN)

CAPS Rating: 3 out of 5

A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.

Recs

0
Player Avatar julianna8 (< 20) Submitted: 10/20/2010 11:56:28 AM : Outperform Start Price: $10.68 AMLN Score: +129.13

dirt cheap at $9.75

Featured Broker Partners


Advertisement